Radioprotective Effects of Vitexina for Breast Cancer Patients Undergoing Radiotherapy With Cobalt-60
Tran Van Hien, PhD, Nguyen Boi Huong, PhD, Pham Manh Hung, DSc, and Nguyen Ba Duc, MS Vitexina, a product containing the flavonoid vitexin as the main component, is derived from a plant, Vigna radiata (L.), that has been traditionally used in Vietnam for detoxification. This remedy is also used to treat the symptoms of conditions classified as "hot" in traditional medicine. The present study is a randomized, placebo-controlled comparative clinical trial for investigating the radioprotective effects of Vitexina for breast cancer patients undergoing radiotherapy with cobalt-60. No relevant weight loss, (even weight gain), occurred in 70% of patients in the Vitexina group, whereas 73% of the placebo group lost 1 to 2 kg of weight after 6 weeks of radiation therapy. The administration of Vitexina produced a significantly protective effect in peripheral blood cells in amount and in lymphocyte blast-transformation function. Condition of hot was observed in almost all cancer patients in this study by tongue examination. Hot condition did not change in the Vitexina group, but the incidence of hot and extreme hot cases were significantly increased in the placebo group after 6 weeks of radiation therapy. The results suggest that application of medicinal plants of the "clearing heat and detoxification" classification as an adjuvant would be a potential solution in integrative cancer therapy.
It is well known that exposure to high-energy radiation can cause damage to biological systems. This effect has been exploited in treating cancer, as cancer cells are damaged by radiation. However, in the process, adjacent healthy tissue is also damaged. The protection of healthy tissue during radiotherapy for cancer has been one of the strong motivations for continuing research on exogenous radioprotectors. 12 Radiation damage in biological systems is initiated by the primary toxic, excited and free radical species formed during energy deposition events. Radiation damage is well known to occur with the free radical burst, leading to oxidative stress in cells and tissue. The application of synthetic antioxidants to protect cells and limit radiation injury might thus benefit patients during treatment. But use of synthetic antioxidants has been restricted due to their toxicity. As a result, interest has grown in development of natural antioxidants from botanical sources. Flavonoidcontaining botanicals are of major interest as plantbased antioxidants.'
The product employed in this study, Vitexina, is derived from a plant, Vigna radiata (L.) Wilczek (Fabaceae) (synonyms Vigna aureus [Roxb.] Hepper, Phaseolus aureus Roxb.), common name dau xanh, the green or mung bean, which has been empirically used in Vietnam for detoxification.~ Vitexina is not yet commercially available in Vietnam; it is currently under review for marketing approval by the Ministry of Health. V aureus has traditionally been used to remove food toxins and alcohol from the body; it is also used to treat the symptoms of conditions classified as &dquo;hot&dquo; in traditional Vietnamese medicine, such as dysentery. The product was shown to be a promising antioxidant radioprotective agent in a series of experimental studies conducted by the research team of the Vietnam Institute of Traditional Medicine.5 The plant is also a common foodstuff in Vietnam; the product thus has a large margin of safety. Acute and subchronic toxicity assays have confirmed this statement.&dquo;
The present study examines the use of Vitexina as a supportive therapy for breast cancer patients undergoing radiation therapy after initial surgery. The objectives of the study are as follows: Clinical Trial Methodology The present study is a randomized, placebo-controlled comparative clinical trial. Patients were recruited from the Department of Radiation No. 2, Cancer Hospital in Hanoi; the patient population included patients with stage II or stage III breast cancer for whom radiation treatment was indicated following surgery for primary breast cancer. The study was conducted from May to October 1999. Ethical review of the trial was conducted by the National Center for Cancer in Hanoi. Trial details were presented on informed consent forms. Patients who consented to participate in the trial were assigned to treatment with Vitexina (Vitexina group) or placebo (placebo group); each group had 36 patients. Exclusion criteria for the trial were as follows : patients with distant metastases, infection with tuberculosis, infection with hepatitis, and patients who did not complete the course of medication or attend the final physical examination. General health criteria including body weight were assessed by a single physician in the Department of Radiation at the Cancer Hospital. The observation of hot and cold symptoms was made by a traditional medicine doctor from the Vietnamese Institute of Traditional Medicine, who was blinded to the group assignment of the patients.
Study Medications
Patients in the Vitexina group received 4 capsules (400 mg active compounds) daily during 6 weeks of radiation therapy, whereas patients in the placebo group 
Radiation Protocol
The total dose of radiation (Cobalt-60) was 5000 rad.
The daily dose was 200 rad, whereas the weekly dose was 800 to 1200 rad divided in 5 courses per week.
Laboratory Analyses
Complete blood counts were performed at the Cancer Hospital laboratory. Blast transformation response of lymphocytes was performed by the Immunology Laboratory of the Institute of Hygiene and Epidemiology in Hanoi. Assessment of hepatic enzyme activities (GOT, GPT) was done at the Vietnamese Institute of Traditional Medicine.
Blast transformation was monitored using the blast transformation test (LTT). Blood samples were taken from patients in the Vitexina and placebo groups before and after 6 weeks of radiation treatment. Blood from healthy people was examined and used as a control. Activation of lymphoblastic transformation was measured by methyl-'H-thymidine incorporation in a liquid scintillation counter. Phytohemagglutinin (PHA) was coincubated together with the lymphocyte culture for 72 hours prior to adding 'H-thymidine. 
Results
Characteristics of patients at entry in the study were similar between the Vitexina and placebo groups. Mean age of patients in the Vitexina group was 45.77 years, whereas mean age for the placebo group was 45.63. Weight of patients in the Vitexina group was 46.82 kg, and in the placebo group, 47.62 kg.
Clinical Symptoms
Side effects frequently found in patients exposed to radiation are headache, restlessness, fatigue, poor sleep, and poor appetite. All patients in the Vitexina group reported to the treating radiation oncologist that side effects were not noticeable, that they had good appetite, and that they slept well during the course of radiation treatment.
Data on weight changes were extracted from medical charts. No relevant weight loss, or even a weight gain, occurred in 70% of patients in the Vitexina group, whereas 73% of the placebo group lost 1 to 2 kg of weight after 6 weeks of radiation therapy (Table 1 Table 2 and summarized in Figure 2 . The data indicate an advantage for the Vitexina group in erythrocyte, leukocyte, and platelet counts as well as hemoglobin after 6 weeks of radiation therapy. Erythrocyte counts and hemoglobin improved in the Vitexina group but declined in the placebo group. Leukocyte and platelet counts declined to approximately 80% of original values in the Vitexina group and to approximately 60% of original values in the placebo group. Among the patients in the Vitexina group, 67% experienced a reduction in platelet counts of less than 20% whereas only 17% of placebo patients experienced a reduction this low (Figure 3 ).
Peripheral Blood Cell Counts A comparison of the results of hematological examination is presented in

Effects of Vitexina in Lymphocyte
Blast Transformation Immune responsiveness in cancer patients is generally deficient and becomes more seriously so when patients are exposed to radiation. One effect of high-energy radiation is damage to T and B lymphocytes. Blast transformation activity of lymphocytes was used to monitor the immune status. The data obtained show that there was a reduction of the response to PHA in cancer patients after surgery in comparison with the response in healthy people. The LTT activity measured in lymphocytes from healthy controls after 72 hours incubation with PHA is about 6000 to 8000 pulses per minute (ppm). No significant difference in the means of LTT values between the 2 experimental groups was observed before radiation treatment; the range of these values was found to be 2000 to 3000 ppm. The second measurement showed that there was some improvement in patients receiving Vitexina in comparison to the controls. In most subjects analyzed in the Vitexina group, lymphocytes still responded to blast transformation initiated by PHA, whereas this response was almost absent in the placebo group. This effect was not confirmed statistically, as insufficient data from the 2 groups were obtained for analysis.
Cold-Hot Status Before and After Radiation Treatment t
According to the experience of experts in traditional medicine, the syndrome of deficiency-hot as classified in Vietnamese traditional medicine is commonly observed in cancer patients. Hot symptoms were observed in breast cancer patients in this study. They seem to be increased by radiation therapy. The Vitexina used in supportive therapy in this study was evaluated for its activity in the improvement of hot symptoms of radiation-exposed cancer patients. Results of tongue examination are shown in Figure 4 . In the normal con- Figure 2 Changes m levels of erythrocytes, hemoglobin, leukocytes, and platelets m breast cancer patients following 6 weeks of radiation therapy, plus Vitexina or placebo. dition, the tongue has a white coating; the tongue tissue is pale pink in color. In patients with hot symptoms, the tongue has a thick white or yellow coating and the tongue tissue is pink. In patients with extreme hot symptoms, the tongue coating is dry and yellow, or lacking entirely, and the tongue tissue is dark pink.
Whereas the incidence of normal, hot, and extreme hot symptoms was similai between the Vitexina and placebo groups at the start of radiation therapy, the incidence of hot and extreme hot symptoms was increased in the placebo group after 6 weeks of radiation. Degree of tongue coating and color of tongue tissue were affected in the same pattern.
Discussion
Six weeks of treatment with Vitexina (400 mg per day) appeared to improve the general health of breast cancer patients during the course of treatment, with resto- Table 3 .
Rate of Cases in Which the Reduction of Platelet
Counts is Less Than 20% ration of peripheral blood cells as well as lymphocyte functions. These effects might result from the antioxidative mechanisms of the active principles in the product. Radiation damage in biological systems is initiated by the oxidative burst of free radicals and then by a cascade of free radical reactions. This event influences first the peripheral blood cells. The reduction in erythrocytes, leukocytes, platelets, and hemoglobin has been reported by others and was confirmed in this study. In the Vitexina group, blood counts were significantly higher than in the placebo group after radiation therapy, as shown in Tables 2 and 3, particularly with regard to platelets, suggesting a radioprotective effect for Vitexina. Because of the known antioxidant properties of Vitexina, we suggest that this effect is due to the inhibition of free radical induced lipid peroxidation.
An effect of Vitexina on the Vietnamese traditional medicine concept of deficiency-hot was indicated in this study based on tongue examination and other clinical symptoms such as fatigue, restlessness, poor sleep, and constipation. Radiation treatment is typically found to aggravate hot symptoms. However, the clinical assessments of hot symptoms did not change in the Vitexina group, whereas symptoms of extreme hot and hot were found in almost all patients in the placebo group after 6 weeks of radiation therapy. Vitexina is extracted from V radiata, which belongs to the &dquo;clearing heat and detoxification&dquo; classification of Vietnamese traditional medicine. Thus, the application of a &dquo;clearing heat and detoxification&dquo; agent to ameliorate damage caused by radiation conforms to the therapeutic principles of traditional medicine.
Radioprotective effects of Vitexina observed from the trial suggest that cancer, oxidative stress, and the deficiency-hot syndrome of cancer patients may be related, and that a potential solution would be to apply the medicinal plants of the &dquo;clearing heat and detoxifi-cation&dquo; classification, which are commonly rich in flavonoid compounds with antioxidant activity.
Further studies are necessary to confirm the beneficial outcome of Vitexina in combined treatment for cancer patients and to investigate the effects of this product on improvement of nonspecific immunological response. We are now beginning a study of breast cancer patients treated with surgery, radiation therapy, and Vitexina in which recurrence, survival, and immune responsiveness will be monitored prospectively. Editor's Note Readers from North America and Europe may not be familiar with the differences between radiation therapy using linear accelerators, which is common in their regions, and therapy using cobalt-60, discussed in the article by Tran Van Hien and colleagues. The radiation dosages used in this article are comparable to those used internationally. However, with cobalt-60, the distribution of the dose is frequently less even than with linear accelerators, and there is less ability to develop skin-sparing dose regimens, according to Dr. Terry Bugno, whose contribution appears in this issue's Integrative Tumor Board. Skin effects are not discussed in this article, but it would be of interest whether this Vietnamese group examined skin effects in future clinical studies with Vitexina to determine whether this antioxidant preparation would be useful for such effects. For readers not familiar with the classifications of &dquo;hot&dquo; conditions in Vietnamese traditional medi-
